Pilocarpine Hydrochloride Ophthalmic Solution USP (Sterile)

Manufacturer
Rebel Distributors Corp
Effective date
2011-03-15
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:11:30

Label at a glance#

ProductPILOCARPINE HYDROCHLORIDE
Active ingredientPILOCARPINE HYDROCHLORIDE
Label structure11 sections

Indications and uses

Pilocarpine hydrochloride can be used in the medical management of glaucoma, especially open-angle glaucoma, in those cases in which the intraocular pressure can be controlled adequately by the topical administration of pilocarpine. In acute (closed-angle) glaucoma, pilocarpine hydrochloride may be used alone, or in combination with other cholinergic agents or carbonic anhydrase inhibitors, to relieve tension prio...

Dosage and administration

The initial dose is one or two drops in the affected eye(s). This may be repeated up to three or four times daily or as directed by a physician. The frequency of instillation and concentration of pilocarpine hydrochloride ophthalmic solution are determined by the severity of the glaucoma and miotic response of the patient. Individuals with heavily pigmented irides may require higher strengths. During acute phases,...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx only

DESCRIPTION:

DESCRIPTION SECTION

Pilocarpine Hydrochloride is a cholinergic prepared as a sterile topical ophthalmic solution. The active ingredient is represented by the chemical structural formula:

Pilocarpine Hydrochloride chemical structural formula
Pilocarpine Hydrochloride chemical structural formula

C11H16N2O2•HCl

Mol. Wt. 244.72

2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl] - monohydrochloride, [3S-cis] -

Pilocarpine HCI 0.5%

EACH mL CONTAINS: ACTIVE: Pilocarpine Hydrochloride 10 mg (1%); INACTIVES: Hypromellose, boric acid, sodium citrate, sodium chloride, Purified Water. Sodium Hydroxide (added to adjust pH).
PRESERVATIVE ADDED: Benzalkonium Chloride 0.01%.

Pilocarpine HCI 4%

EACH mL CONTAINS: ACTIVE: Pilocarpine Hydrochloride 40 mg (4%); INACTIVES: Hypromellose, Monobasic Sodium Phosphate, Edetate Disodium, Dibasic Sodium Phosphate, Purified Water. Sodium Hydroxide and/or Hydrochloric Acid may be added to adjust pH (3.5 - 5.5). PRESERVATIVE ADDED: Benzalkonium Chloride 0.01%.

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

The actions of pilocarpine hydrochloride are those of pilocarpine, a cholinergic substance. Its penetration, following topical application to the eye, results in parasympathomimetic reactions by responsive tissues.

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

Pilocarpine hydrochloride can be used in the medical management of glaucoma, especially open-angle glaucoma, in those cases in which the intraocular pressure can be controlled adequately by the topical administration of pilocarpine. In acute (closed-angle) glaucoma, pilocarpine hydrochloride may be used alone, or in combination with other cholinergic agents or carbonic anhydrase inhibitors, to relieve tension prior to emergency surgery.

Patients may be maintained on pilocarpine hydrochloride as long as intraocular pressure is controlled and there is no deterioration in the visual fields. The choice of concentration should be determined by the severity of the condition and the response of the patient. Pilocarpine hydrochloride is also indicated to counter the effects of cycloplegics and mydriatics following surgery or ophthalmoscopic examination.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

Parasympathomimetics are contraindicated where miosis is undesirable such as acute iritis or pupillary block glaucoma.

This product is also contraindicated in persons hypersensitive to one or more of the components of this preparation.

WARNINGS:

WARNINGS SECTION

Not for internal use. To prevent contaminating the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle.

PRECAUTIONS:

PRECAUTIONS SECTION

This pilocarpine-induced miosis may cause difficulty in dark adaptation. The patient should exercise caution when involved in night driving or other hazardous activities in poor light.

Carcinogenesis, Mutagenesis, Impairment of Fertility:

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

There have been no long-term studies done using pilocarpine in animals to evaluate carcinogenic potential.

Pregnancy Category C:

PREGNANCY SECTION

Animal studies have not been conducted with pilocarpine. It is also not known whether pilocarpine can cause fetal harm when administered to a pregnant women or can affect reproduction capacity. Pilocarpine should be given to a pregnant women only if clearly needed.

Nursing Mothers:

NURSING MOTHERS SECTION

It is not known whether the drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when pilocarpine is administered to a nursing woman.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

OCULAR: Transient symptoms of stinging and burning may occur. Ciliary spasm, conjunctival vascular congestion, temporal or supraorbital headache, lacrimation and induced myopia may occur. This is especially true in younger individuals who have recently started administration. Reduced visual acuity in poor illumination is frequently experienced by older individuals and individuals with lens opacity. Miotic agents may also cause retinal detachment; thus, care should be exercised with all miotic therapy especially in young myopic patients. Lens opacity may occur with prolonged use of pilocarpine.

SYSTEMIC: Systemic reactions following topical administration, although extremely rare, have included hypertension, tachycardia, bronchiolar spasm, pulmonary edema, salivation, sweating, nausea, vomiting, and diarrhea.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

The initial dose is one or two drops in the affected eye(s). This may be repeated up to three or four times daily or as directed by a physician. The frequency of instillation and concentration of pilocarpine hydrochloride ophthalmic solution are determined by the severity of the glaucoma and miotic response of the patient. Individuals with heavily pigmented irides may require higher strengths.

During acute phases, the miotic must be instilled into the unaffected eye to prevent an attack of angle-closure glaucoma.

DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT.

HOW SUPPLIED

HOW SUPPLIED SECTION

Pilocarpine Hydrochloride Ophthalmic Solution USP is supplied in 15 ml plastic DROP-TAINER* dispensers.

Boxed Warning section

Pilocarpine HCl Ophthalmic Solution USP, 1%
15 mL - NDC 21695-368-01

SPL Unclassified section

*DROP-TAINER is a registered trademark of Alcon Manufacturing Ltd.

NOT FOR INJECTION.

FOR OPHTHALMIC USE ONLY.

STORAGE: Store between 8°- 27°C (46°- 80°F).

KEEP OUT OF REACH OF CHILDREN.

Manufactured by: ALCON LABORATORIES, INC, Fort Worth, TX 76134

Distributed by: FALCON PHARMACEUTICALS LTD., Fort Worth, TX 76134

Repackaged by: REBEL DISTRIBUTORS CORP, Thousand Oaks, CA 91320

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Pilocarpine HCl 1%
Pilocarpine HCl 1%

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1000647pilocarpine HCl 1 % Ophthalmic SolutionPSN1
1000647pilocarpine hydrochloride 10 MG/ML Ophthalmic SolutionSCD1
1000647pilocarpine hydrochloride 1 % Ophthalmic SolutionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
PILOCARPINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
92fc48b4-3815-4611-a8be-f74b29f9b350Product name220260130
c8f45a17-34ae-46eb-871b-470615085910Product name120250630
dad00d81-2cbe-bbab-dd06-a12043b5e56dProduct name420210512
419b812f-d1a6-2de2-5dee-bec68d6ec699Product name220200123
38c480e0-b6d3-b416-6514-a787406e5176Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
21695-368-012019-09-24C16284748780-1934fe258-4d52-48b1-e053-8cdaa90a720aPilocarpine Hydrochloride Ophthalmic Solution USP (Sterile)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
21695-368-01PILOCARPINE HYDROCHLORIDE15 mL in 1 BOTTLE, PLASTICSOLUTION/ DROPS151
21695-368-01PILOCARPINE HYDROCHLORIDE1 in 1 CARTONSOLUTION/ DROPS11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
21695-368PILOCARPINE HYDROCHLORIDE SOLUTION/ DROPS [REBEL DISTRIBUTORS CORP]1Legacy NDC, 2 package rows20110316_d2ded29a-448d-4c4a-9307-403836a67da4.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
61314-203-15ML - Milliliter61314-203d1e6401f-362e-4d2e-bc42-4bdd2d1f0b5c12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
PILOCARPINE HYDROCHLORIDEACTIVE INGREDIENT0WW6D218XJ1
PILOCARPINEACTIVE MOIETY01MI4Q9DI31
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W71
BORIC ACIDINACTIVE INGREDIENTR57ZHV85D41
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CB1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WO1
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8X1
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULR1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
21695-36821695-368-01
61314-203

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 8 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
BORIC ACIDBORIC ACIDR57ZHV85D4SOLUTION/ DROPS / OPHTHALMIC48 mgExact identifier — unii+route+dosage form
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSUSPENSION / OPHTHALMIC0.5 %w/wExact identifier — unii+route
3 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii+route+dosage form
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / OPHTHALMIC55 mgExact identifier — unii+route+dosage form
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii+route
3 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSUSPENSION/ DROPS / OPHTHALMIC3 mgExact identifier — unii+route
3 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N200890-001ISOPTO CARPINEPILOCARPINE HYDROCHLORIDE1%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-22
N200890-002ISOPTO CARPINEPILOCARPINE HYDROCHLORIDE2%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-22
N200890-003ISOPTO CARPINEPILOCARPINE HYDROCHLORIDE4%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
N200890-001AT
N200890-002AT
N200890-003AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N200890-001ISOPTO CARPINE1%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-2284e616aacf4f…
2026-09-14 22:38:342026-08N200890-002ISOPTO CARPINE2%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-2284e616aacf4f…
2026-09-14 22:38:342026-08N200890-003ISOPTO CARPINE4%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-2284e616aacf4f…
2026-08-18 06:07:402026-07N200890-001ISOPTO CARPINE1%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-22caaa826d4ba7…
2026-08-18 06:07:402026-07N200890-002ISOPTO CARPINE2%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-22caaa826d4ba7…
2026-08-18 06:07:402026-07N200890-003ISOPTO CARPINE4%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-22caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N200890-001ISOPTO CARPINE1%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N200890-002ISOPTO CARPINE2%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N200890-003ISOPTO CARPINE4%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N200890-001ISOPTO CARPINE1%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N200890-002ISOPTO CARPINE2%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N200890-003ISOPTO CARPINE4%SOLUTION/DROPS / OPHTHALMICATRLD, RS2010-06-2231067a03dcf5…
2025-08-23 18:47 UTC2025-08N200890-001ISOPTO CARPINE1%SOLUTION / OPHTHALMICATRLD, RS2010-06-226a471c1ec25d…
2025-08-23 18:47 UTC2025-08N200890-002ISOPTO CARPINE2%SOLUTION / OPHTHALMICATRLD, RS2010-06-226a471c1ec25d…
2025-08-23 18:47 UTC2025-08N200890-003ISOPTO CARPINE4%SOLUTION / OPHTHALMICATRLD, RS2010-06-226a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N200890-001ISOPTO CARPINE1%SOLUTION / OPHTHALMICATRLD, RS2010-06-22fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N200890-002ISOPTO CARPINE2%SOLUTION / OPHTHALMICATRLD, RS2010-06-22fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N200890-003ISOPTO CARPINE4%SOLUTION / OPHTHALMICATRLD, RS2010-06-22fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N200890-001ISOPTO CARPINE1%SOLUTION / OPHTHALMICATRLD, RS2010-06-22b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N200890-002ISOPTO CARPINE2%SOLUTION / OPHTHALMICATRLD, RS2010-06-22b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N200890-003ISOPTO CARPINE4%SOLUTION / OPHTHALMICATRLD, RS2010-06-22b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N200890-001ISOPTO CARPINE1%SOLUTION / OPHTHALMICATRLD, RS2010-06-2203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N200890-002ISOPTO CARPINE2%SOLUTION / OPHTHALMICATRLD, RS2010-06-2203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N200890-003ISOPTO CARPINE4%SOLUTION / OPHTHALMICATRLD, RS2010-06-2203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N200890-001ISOPTO CARPINE1%SOLUTION / OPHTHALMICATRLD, RS2010-06-222680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N200890-002ISOPTO CARPINE2%SOLUTION / OPHTHALMICATRLD, RS2010-06-222680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N200890-003ISOPTO CARPINE4%SOLUTION / OPHTHALMICATRLD, RS2010-06-222680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N200890-001ISOPTO CARPINE1%SOLUTION / OPHTHALMICATRLD, RS2010-06-225bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N200890-002ISOPTO CARPINE2%SOLUTION / OPHTHALMICATRLD, RS2010-06-225bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N200890-003ISOPTO CARPINE4%SOLUTION / OPHTHALMICATRLD, RS2010-06-225bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N200890-001ISOPTO CARPINE1%SOLUTION / OPHTHALMICATRLD, RS2010-06-22d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N200890-002ISOPTO CARPINE2%SOLUTION / OPHTHALMICATRLD, RS2010-06-22d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N200890-003ISOPTO CARPINE4%SOLUTION / OPHTHALMICATRLD, RS2010-06-22d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N200890-001ISOPTO CARPINE1%SOLUTION / OPHTHALMICATRLD, RS2010-06-22d06236e962d9…
2024-10-29 15:01 UTC2024-10N200890-002ISOPTO CARPINE2%SOLUTION / OPHTHALMICATRLD, RS2010-06-22d06236e962d9…
2024-10-29 15:01 UTC2024-10N200890-003ISOPTO CARPINE4%SOLUTION / OPHTHALMICATRLD, RS2010-06-22d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N200890-001ISOPTO CARPINE1%SOLUTION / OPHTHALMICATRLD, RS2010-06-2279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N200890-002ISOPTO CARPINE2%SOLUTION / OPHTHALMICATRLD, RS2010-06-2279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N200890-003ISOPTO CARPINE4%SOLUTION / OPHTHALMICATRLD, RS2010-06-2279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N200890-001ISOPTO CARPINE1%SOLUTION / OPHTHALMICATRLD, RS2010-06-22301d65b070ca…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08N200890-001AT184e616aacf4f…
2026-09-14 22:38:342026-08N200890-002AT184e616aacf4f…
2026-09-14 22:38:342026-08N200890-003AT184e616aacf4f…
2026-08-18 06:07:402026-07N200890-001AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N200890-002AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N200890-003AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N200890-001AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N200890-002AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N200890-003AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N200890-001AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N200890-002AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N200890-003AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08N200890-001AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N200890-002AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N200890-003AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N200890-001AT1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N200890-002AT1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N200890-003AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N200890-001AT1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N200890-002AT1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N200890-003AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N200890-001AT103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N200890-002AT103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N200890-003AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N200890-001AT12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N200890-002AT12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N200890-003AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N200890-001AT15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N200890-002AT15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N200890-003AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N200890-001AT1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N200890-002AT1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N200890-003AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N200890-001AT1d06236e962d9…
2024-10-29 15:01 UTC2024-10N200890-002AT1d06236e962d9…
2024-10-29 15:01 UTC2024-10N200890-003AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N200890-001AT179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N200890-002AT179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N200890-003AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N200890-001AT1301d65b070ca…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pilocarpine HydrochloridePILOCARPINE HYDROCHLORIDESandoz Inc53fa0b7a-f982-48a7-92c4-6f098683c1ed2020-05-19Warnings, Adverse reactionsExact identifier
ndc (product): 61314-203
d2ded29a-448d-4c4a-9307-403836a67da4d2ded29a-448d-4c4a-9307-403836a67da42011-03-15Boxed warning, Warnings, Adverse reactionsExact identifier
spl id: d2ded29a-448d-4c4a-9307-403836a67da4
spl set id: d2ded29a-448d-4c4a-9307-403836a67da4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.